Yuanbao Inc. American Depositary Shares
NASDAQ Global MarketRecent
price
P/E
ratio
div
yld
- -
ROIC.AI
Capital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.- Similar Companies
- Business
- Yuanbao Inc. (Nasdaq: YB) is a leading technology-driven online insurance distributor in the People's Republic of China. The company, founded in 2019 and headquartered at Building 2, No. 8 Beichen West Road, Chaoyang District, Beijing, operates through subsidiaries including Yuanbao Insurance Broker (Beijing) Co., Ltd., which holds a nationwide insurance brokerage license. It primarily serves Chinese consumers and insurance carriers via an AI-powered platform featuring a full consumer service cycle engine with over 4,900 interconnected models and 5,500 labels for personalized recommendations, policy management, claims processing, and post-sales services; products encompass short-term medical insurance, critical illness insurance (including innovative short-term options with hybrid lump-sum payment plus multiple reimbursements), accident insurance, life insurance, and other personal life and accident & health (A&H) coverage distributed from 46+ partnered carriers; system services include precise marketing, analytics, and technology solutions to optimize carrier distribution and consumer engagement across all mainland provinces. Yuanbao targets middle-class families seeking affordable, high-value protection in underserved segments, generating revenues from insurance distribution and system services while maintaining nationwide operations. Recent developments include its April 2025 Nasdaq IPO raising $30 million through 2 million American Depositary Shares priced at $15 (with a concurrent $1 million private placement to Qiming Venture Partners), robust Q3 2025 unaudited results showing 33.6% year-over-year revenue growth to RMB1.16 billion driven by 41.8% new policy increase to 8.0 million and AI enhancements like LLM-assisted modeling, and launches of inclusive critical illness products co-developed with carriers.
Company News
Citizens (NYSE:CIA) vs. Yuanbao (NASDAQ:YB) Head to Head Review
Yuanbao (NASDAQ:YB) Reaches New 52-Week Low – Time to Sell?
Yuanbao: Still Worth Hanging On To
Yuanbao: Bullish On Earnings Growth Acceleration And Dividend Commitment
Yuanbao Inc. (YB) Q2 2026 Earnings Call Transcript
Yuanbao Q2 Earnings Call Highlights
Yuanbao Inc. Announces Second Quarter 2026 Unaudited Financial Results
Yuanbao Inc. to Announce Second Quarter 2026 Financial Results on Thursday, September 10, 2026
Yuanbao Inc: Has Enough Going For It To Take It Higher
Yuanbao: I Think The Market Is Overpricing The Risks
Yuanbao Inc. (YB) Q1 2026 Earnings Call Transcript
Why Yuanbao Stock Is Skyrocketing Today
Yuanbao Q1 Earnings Call Highlights
Yuanbao Inc. Announces First Quarter 2026 Unaudited Financial Results
Yuanbao Inc. to Announce First Quarter 2026 Financial Results on Wednesday, June 10, 2026
Yuanbao Inc. Files its Annual Report on Form 20-F for Fiscal Year 2025
James River Group (NASDAQ:JRVR) and Yuanbao (NASDAQ:YB) Head-To-Head Survey
Sompo (OTCMKTS:SMPNY) vs. Yuanbao (NASDAQ:YB) Financial Analysis
Yuanbao Inc. (YB) Q4 2025 Earnings Call Transcript
Yuanbao Inc. Announces Fourth Quarter and Fiscal Year 2025 Unaudited Financial Results